Galectin Therapeutics
GALT
GALT
51 hedge funds and large institutions have $7.02M invested in Galectin Therapeutics in 2015 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
95% less call options, than puts
Call options by funds: $4K | Put options by funds: $85K
Holders
51
Holding in Top 10
–
Calls
$4K
Puts
$85K
Top Buyers
| 1 | +$401K | |
| 2 | +$104K | |
| 3 | +$36.1K | |
| 4 |
Creative Planning
Overland Park,
Kansas
|
+$18K |
| 5 |
Millennium Management
New York
|
+$13.9K |
Top Sellers
| 1 | -$3.25M | |
| 2 | -$560K | |
| 3 | -$502K | |
| 4 |
D.E. Shaw & Co
New York
|
-$384K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$275K |